Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.

Middleton D, Diler AS, Meenagh A, Sleator C, Gourraud PA.

Tissue Antigens. 2009 Jun;73(6):553-60. doi: 10.1111/j.1399-0039.2009.01235.x.

PMID:
19493232
2.

Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers.

Löfström B, Backlin C, Sundström C, Hellström-Lindberg E, Ekbom A, Lundberg IE.

Rheumatology (Oxford). 2009 Oct;48(10):1222-6. doi: 10.1093/rheumatology/kep204. Epub 2009 Jul 16. Review.

PMID:
19608725
3.

[Pathological features of neuroleukemia. Changes and lessons].

Garzuly F.

Orv Hetil. 1994 Jun 12;135(24):1291-5. Review. Hungarian.

PMID:
8015823
4.

Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable?

Riley CL, Mathieu MG, Clark RE, McArdle SE, Rees RC.

Cancer Immunol Immunother. 2009 Sep;58(9):1489-99. doi: 10.1007/s00262-009-0675-x. Epub 2009 Mar 4. Review.

PMID:
19259670
5.

Rare translocations involving chromosome band 8p11 in myeloid neoplasms.

Lee SG, Park TS, Lee ST, Lee KA, Song J, Kim J, Suh B, Choi JR, Park R.

Cancer Genet Cytogenet. 2008 Oct 15;186(2):127-9. doi: 10.1016/j.cancergencyto.2008.07.002. Review. No abstract available.

PMID:
18940479
6.

Current status of gene expression profiling in the diagnosis and management of acute leukaemia.

Bacher U, Kohlmann A, Haferlach T.

Br J Haematol. 2009 Jun;145(5):555-68. doi: 10.1111/j.1365-2141.2009.07656.x. Epub 2009 Mar 16. Review.

PMID:
19344393
7.

The impact of gene profiling in chronic myeloid leukaemia.

Yong AS, Melo JV.

Best Pract Res Clin Haematol. 2009 Jun;22(2):181-90. doi: 10.1016/j.beha.2009.04.002. Review.

PMID:
19698927
8.

NCCN task force report: molecular markers in leukemias and lymphomas.

Radich JP, Zelenetz AD, Chan WC, Croce CM, Czuczman MS, Erba HP, Horning SJ, Houldsworth J, Smith BD, Snyder DS, Sundar HM, Wetzler M, Winter JN.

J Natl Compr Canc Netw. 2009 Jul;7 Suppl 4:S1-34, quiz S35-6. Review.

PMID:
19635230
9.

Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy.

Keller G, Brassat U, Braig M, Heim D, Wege H, Brümmendorf TH.

Hematol Oncol. 2009 Sep;27(3):123-9. doi: 10.1002/hon.901. Review.

PMID:
19569255
10.

Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.

Foroni L, Gerrard G, Nna E, Khorashad JS, Stevens D, Swale B, Milojkovic D, Reid A, Goldman J, Marin D.

Am J Hematol. 2009 Aug;84(8):517-22. doi: 10.1002/ajh.21457. Review.

11.

Familial occurrence of chronic myeloid leukemia.

Caocci G, Atzeni S, Vacca A, Orrù N, Ledda A, La Nasa G.

Leuk Lymphoma. 2009 May;50(5):854-6. doi: 10.1080/10428190902842634. Review. No abstract available.

PMID:
19452324
12.

Kodamaea (Pichia) ohmeri fungaemia complicating acute myeloid leukaemia in a patient with haemochromatosis.

Mahfouz RA, Otrock ZK, Mehawej H, Farhat F.

Pathology. 2008 Jan;40(1):99-101. Review. No abstract available.

PMID:
18038331

Supplemental Content

Support Center